Therefore, in this study, we evaluated the potential mechanism of the metastatic and invasive promoter, miR‐3677‐3p, in HCC and found that it targeted SIRT5 in hypoxia conditions. The gene discussed is SIRT5; the disease is hepatocellular carcinoma.